InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Legault Pierre, Director. Officer active across 2 companies, notably BICYCLE THERAPEUTICS plc. Cumulatively, 8 disclosures have been published. The latest transaction was disclosed on 2 February 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
Declarations8 total
016,000 shares0
Common Stock
SEC:0001562180-22-001073·
016,000 shares0
Common Stock
SEC:0001562180-22-001073:0·
010,000 shares0
Ordinary Shares
SEC:0001209191-22-001821·
010,000 shares0
Ordinary Shares
SEC:0001209191-22-001821:0·
€125,93920,000 shares@ €6.2970.0070% mcap100.0% of flow
Common Stock
SEC:0001562180-21-007866·
€56,8697,603 shares@ €7.47990.012% mcap100.0% of flow
Ordinary Shares
SEC:0001209191-21-071007·
€56,8697,603 shares@ €7.47990.012% mcap50.0% of flow
Ordinary Shares
SEC:0001209191-21-071007:0·
€125,93920,000 shares@ €6.2970.0070% mcap50.0% of flow
Common Stock
SEC:0001562180-21-007866:0·
8 of 8 declarations
About Legault Pierre
Legault Pierre is a Director at BICYCLE THERAPEUTICS plc and Syndax Pharmaceuticals Inc. In this role, he participates in strategic decision-making and governance of the companies. His experience and skills contribute to guiding the policies and practices of the organizations, ensuring they align with industry best practices. Legault Pierre plays an important role in overseeing the companies' activities.
